Kura Oncology Cash from Investing (TTM) Analysis

Kura Oncology Inc (KURA)

20.28 +0.66 (+3.36%) USD | NASDAQ | May 01, 16:00

20.26 -0.02 (-0.10%) Pre-Market: 20:00

Cash from Investing (TTM) Chart

Historical Cash from Investing (TTM) Data

View and export this data back to 2015. Upgrade now.

Date	Value
December 31, 2023	15.56M
September 30, 2023	-73.96M
June 30, 2023	-10.70M
March 31, 2023	68.72M
December 31, 2022	32.63M
September 30, 2022	154.01M
June 30, 2022	104.74M
March 31, 2022	34.42M
December 31, 2021	-126.84M
September 30, 2021	-261.09M
June 30, 2021	-329.15M
March 31, 2021	-313.62M
December 31, 2020	-99.94M
September 30, 2020	-55.00M
June 30, 2020	-65.24M
March 31, 2020	-34.67M
December 31, 2019	-46.32M

Date	Value
September 30, 2019	-26.45M
June 30, 2019	-28.76M
March 31, 2019	-33.78M
December 31, 2018	-79.30M
September 30, 2018	-88.01M
June 30, 2018	-66.24M
March 31, 2018	-62.67M
December 31, 2017	-23.42M
September 30, 2017	-9.647M
June 30, 2017	26.79M
March 31, 2017	13.52M
December 31, 2016	12.18M
September 30, 2016	-37.95M
June 30, 2016	-41.98M
March 31, 2016	-62.42M
December 31, 2015	-70.63M

Cash From Investing Definition

Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.

Read full definition.

Cash from Investing (TTM) Range, Past 5 Years

-329.15M

Minimum

Jun 2021

154.01M

Maximum

Sep 2022

-55.88M

Average

-34.67M

Median

Mar 2020

Cash from Investing (TTM) Benchmarks